Atea Pharmaceuticals, Inc. (AVIR) - Winst- en verliesrekening per kwartaal

Home
AVIR
Financiële Gegevens

3.35 (USD) • At close December 31, 2024

Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1	2019 Q4	2019 Q3	2019 Q2	2019 Q1
Omzet Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	192.18	32.811	60.391	65.985	48.633	0	0	0	0	0	0	0
Kosten van de omzet Numbers are in millions	0	0.104	0.104	0.104	0.104	0.104	0.104	0.104	15.148	0.043	0.023	0.007	43.019	39.803	26.571	13.846	13.601	7.755	2.821	10.17	0	0	0
Brutowinst Numbers are in millions	0	-0.104	-0.104	-0.104	-0.104	-0.104	-0.104	-0.104	-15.148	-0.043	-0.023	192.173	-10.208	20.588	39.414	34.787	-13.601	-7.755	-2.821	-10.17	0	0	0
Brutowinstmarge Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	1	-0.311	0.341	0.597	0.715	0	0	0	0	0	0	0
Onderzoek- en ontwikkelingskosten Numbers are in millions	26.159	34.696	57.575	35.045	28.181	22.063	28.954	27.54	4.905	19.858	29.633	57.811	43.019	39.803	26.571	13.846	13.601	7.755	2.821	3.489	2.411	2.826	1.444
Algemene en administratieve kosten Numbers are in millions	11.043	12.22	12.231	11.528	12.604	13.172	12.615	12.359	11.376	12.437	12.542	13.188	11.939	11.901	8.759	14.14	4.028	2.248	1.224	1.26	1.358	0.892	0.928
Verkoop- en marketingkosten Numbers are in millions	0	-0.104	-0.104	-0.104	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Verkoop-, algemene en administratieve kosten Numbers are in millions	11.043	12.116	12.127	11.424	12.604	13.172	12.615	12.359	11.376	12.437	12.542	13.188	11.939	11.901	8.759	14.14	4.028	2.248	1.224	1.26	1.358	0.892	0.928
Overige kosten Numbers are in millions	0	-23.209	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Bedrijfskosten Numbers are in millions	37.202	46.812	69.702	46.469	40.785	35.235	41.569	39.899	16.281	32.295	42.175	70.999	54.958	51.704	35.33	27.986	17.629	10.003	4.045	4.749	3.769	3.718	2.372
Bedrijfsresultaat Numbers are in millions	-37.202	-46.916	-69.806	-46.573	-40.785	-35.235	-41.569	-39.899	-16.281	-32.295	-42.175	121.181	-22.147	8.687	30.655	20.647	-17.629	-10.003	-4.045	-4.749	-3.769	-3.718	-2.372
Bedrijfsresultaat ratio Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0.631	-0.675	0.144	0.465	0.425	0	0	0	0	0	0	0
Totaal overige inkomsten en kosten netto Numbers are in millions	6.277	6.637	6.868	7.758	7.864	7.303	6.299	5.591	4.382	1.08	0.098	0.051	0.053	0.052	0.058	0.009	0.007	0.01	0.057	0.094	0.137	0.164	0.179
Inkomen voor belasting Numbers are in millions	-30.925	-40.279	-62.938	-38.815	-32.921	-27.932	-35.27	-34.308	-11.899	-31.215	-42.077	121.232	-22.094	8.739	30.713	20.656	-17.622	-9.993	-3.988	-4.655	-3.632	-3.554	-2.193
Inkomen voor belasting ratio Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0.631	-0.673	0.145	0.465	0.425	0	0	0	0	0	0	0
Belastingkosten Numbers are in millions	0.226	0.243	0.231	0.349	0.221	0.251	0.197	0.123	-3.833	0.12	-0.098	4.1	6.1	7.2	0	0	0	0	0	0	0	0	0
Nettowinst Numbers are in millions	-31.151	-40.522	-63.169	-39.164	-33.142	-28.183	-35.467	-34.431	-8.066	-31.335	-41.979	117.132	-28.194	1.539	30.713	20.656	-17.622	-9.993	-3.988	-4.655	-3.632	-3.554	-2.193
Nettowinstmarge Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0.609	-0.859	0.025	0.465	0.425	0	0	0	0	0	0	0
WPA (Winst Per Aandeel) Numbers are in millions	-0.37	-0.48	-0.75	-0.47	-0.4	-0.34	-0.43	-0.41	-0.097	-0.38	-0.5	1.41	-0.34	0.02	0.37	0.25	-0.22	-0.21	-0.084	-0.098	-0.077	-0.35	-0.22
Verwaterde WPA Numbers are in millions	-0.37	-0.48	-0.75	-0.47	-0.4	-0.34	-0.43	-0.41	-0.097	-0.38	-0.5	1.34	-0.34	0.02	0.34	0.23	-0.22	-0.21	-0.084	-0.098	-0.077	-0.35	-0.22
EBITDA Numbers are in millions	-37.202	-46.916	-69.702	-38.711	-40.785	-35.235	-41.465	-34.204	-16.281	-32.295	-42.168	121.188	-22.14	8.695	30.662	20.653	-17.624	-9.999	-4.041	-4.745	-3.765	-3.714	-2.367
EBITDA ratio Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0.631	-0.675	0.144	0.465	0.425	0	0	0	0	0	0	0

Atea Pharmaceuticals, Inc.

NASDAQ:AVIR Add to watchlist

NASDAQ:AVIR